Search

Your search keyword '"Woolley AE"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Woolley AE" Remove constraint Author: "Woolley AE"
57 results on '"Woolley AE"'

Search Results

1. A first update on mapping the human genetic architecture of COVID-19

2. Mapping the human genetic architecture of COVID-19

Catalog

Books, media, physical & digital resources

3. Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee.

4. Eighteen-Month Outcomes Among Pregnant and Nonpregnant Reproductive-Aged People Hospitalized for Coronavirus Disease 2019.

6. 18 F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context: ASNC Imaging Indications (ASNC I 2 ) Series Expert Consensus Recommendations From ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS.

7. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS.

8. Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia.

9. Infective Endocarditis Antibiotic Prophylaxis: Review of the Evidence and Guidelines.

10. OPTN required SARS-CoV-2 lower respiratory testing for lung donors: Striking the balance.

12. The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.

13. Diagnostic TR-FRET assays for detection of antibodies in patient samples.

14. Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.

15. Blastomycosis in New England: 5 Cases and a Review.

16. Thrombosis-Related Loss of Arterial Lines in the First Wave of COVID-19 and Non-COVID-19 Intensive Care Unit Patients.

17. Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study.

19. Cluster of Burkholderia cepacia Complex Infections Associated With Extracorporeal Membrane Oxygenation Water Heater Devices.

20. Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System.

21. Prior SARS-CoV-2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography.

22. At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area.

24. Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system.

25. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study.

26. Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.

27. Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.

28. Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes.

29. Serum Sodium, Patient Symptoms, and Clinical Outcomes in Hospitalized Patients with COVID-19.

30. A SARS-CoV-2 Neutralization Assay Using Single Molecule Arrays.

31. Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2.

32. Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease.

33. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.

34. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.

35. Humoral signatures of protective and pathological SARS-CoV-2 infection in children.

36. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.

37. VTE in ICU Patients With COVID-19.

39. Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing.

40. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system.

41. BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation.

43. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.

46. The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.

48. Cardiac hemi-autotransplantation as a new approach to resect complex left atrial neoplasms.

49. Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.

50. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.